Hanna Betsy
Known title: DirectorCIK: 0001885957
Associated companies
Transaction History
| TMCI | ▲ Buy | Grant | 30,000 | $0 | 5/19/2026 | View on chart |
| TMCI | ▲ Buy | Grant | 23,917 | $0 | 5/20/2025 | View on chart |
| TMCI | ▲ Buy | Grant | 15,091 | $0 | 5/21/2024 | View on chart |
| TMCI | ▲ Buy | Grant | 2,753 | $0 | 5/23/2023 | View on chart |
| TMCI | ▲ Buy | Grant | 1,187 | $0 | 5/17/2022 | View on chart |
| TMCI | ▲ Buy | Grant | 2,295 | $0 | 5/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Treace Medical Shares Five-Year Bunion Study Results
Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.
Treace Medical Shares Five-Year Bunion Study Results. Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.